Healthcare Industry in the Philippines: Market Overview and Investment Opportunities in 2026

The 2026 outlook for the healthcare sector in the Philippines is positive. Growth will likely be driven by an imbalance between private sector and public sector investment. There is an increasing investment in healthcare and related services by households, overseas Filipino workers, and an increasing population of corporate payors. Private hospitals and healthcare services, diagnostic and imaging services, health insurers, and digital health services are benefiting from this increased investment. The public healthcare system is not. For investors, this represents an opportunity. Unlike the short cyclical upturns in economic activity, investment in healthcare services, the related infrastructure, and the healthcare technology services will provide a long and sustainable return.

The split public-private model that defines the Philippine healthcare system consists of a public model that covers a largearet of the population, but is often overburdened and a private system with more optimal healthcare that comes at an opportunity cost. Nearly every investment related to Philippine healthcare can be attributed to this market split. The availability of private healthcare is limited to the metropolitan areas of Manila, Cebu and Davao, rendering the remainder of the country underserved and overburdened, relative to population size. The healthcare demand among Overseas Filipino Workers (OFWs) and their dependents is significant, as they are more willing to pay for private healthcare. The trend of private health insurance sponsored by employers is also on the rise, as companies strive to attract and retain talent, and is indicative of the more predictable and frequent influx of new patients compared to the past. There is also a shift in the Philippine healthcare market away from inpatient care to outpatient healthcare and more specialized healthcare services such as oncology, cardiology, and fertility. These are more optimal and carry better margins when compared to other specialized forms of care.

Figures Capturing Market Value

The opportunity being outlined can be captured by a few statistics. Expenditures on health in the Philippines are forecasted to reach about USD 456 PPP per capita by 2026. This increase would be due to the gradual and progressive increase in household and institutional out-of-pocket expenditure on health services—rather than a one-time increase. The value of the Philippines’ pharmaceutical market is approximately USD 3.3 billion, signifying a substantial demand for medicines, and pharmacy and retail pharmacy infrastructures in the archipelago. Though smaller and more nascent, the medical devices market, valued at about USD 747 million, also reflects demand along the same lines, and is likely to grow along the same lines as hospital and diagnostic capacity. Though these statistics are rough estimates, and should be considered as such, the investors should accompany them with the most up-to-date data on government expenditure on health and hospital bed capacity, as healthcare metrics for fast growing economies can substantially change after a single budget cycle.

Where the Investment Opportunities Are

A good number of investment openings are in private hospitals and specialty centers, especially in secondary cities. In some areas, private hospitals have not even come close to Meeting the growing needs of the general public. Some of the fastest growing segments of healthcare provision are networks of diagnostics and laboratories. This is largely due to the increasing needs of the population around preventive healthcare and the growing burden of chronic diseases. This segment is along the value chain of pharmaceutical distribution and retail pharmacy. This is especially interesting in relation to the growing burden of medicine logistics in an archipelago of thousands of islands. Medical devices and consumables, along with the network and distribution of diagnostics, are tied to the expansion of hospitals and clinics. Digital health and telehealth are most likely to provide cover for underserved populations in areas where private hospitals or full service healthcare facilities may never be established. The remaining opportunities are in fragmented and specialized areas of healthcare, real estate, and networks of clinics. These opportunities offer hybrid investment openings and growing segments of the healthcare value chain.

Growth Drivers

Healthcare Growth Drivers
Healthcare Growth Drivers

There are several long-term, structural industry trends that will likely lead to sustained growth in this sector. The growing burden of non-communicable diseases—diabetes, cardiovascular disease, and cancer, to name a few—has shifted the focus of healthcare spending from episodic treatments toward the ongoing, and usually more profitable, management of a condition where the healthcare provider has ongoing relationships with patients. In addition to the above, the world’s population is aging, and the management of chronic illness and the provision of long-term care is in demand. In the coming years, even though the speed of their implementation may vary, positive policy changes to expand universal health care will likely broaden the addressable market of both public and private providers. Due to the lack of capacity in the public health system, private demand has stepped in to fill the void. There has been a growing demand and interest in insurance-backed care, which creates a more reliable form of payment for providers compared to the historically prevalent out of pocket payment model of healthcare.

Risks and Constraints

The investment opportunity presents real challenges. Market grade hospital facilities require a large capital investment and a long payback period, which limits the number of investors able and willing to compete in this market. Regulatory approvals and licenses will add further complications to an already restrictive time frame for market entry and expansion. First time investors are likely to face a worker shortage as well. Physicians and nurses leave the country in search of higher paying opportunities. Access to hospital facilities is uneven across regions and can restrict the market for facilities built outside the large urban areas. Companies relying on public insurance to secure their revenue are also likely to come under more competitive pressure to drop their prices, which is not a concern for companies that rely on private-pay revenue.

What to Look for Before Investing

When evaluating a prospective healthcare investment opportunity in the Philippines, there are some important questions that should be addressed prior to actually investing the capital. What is the actual patient and payer mix? What forms the revenue base — self pay, insurance, corporate contracts, or government payer programs? Is the facility located in a sufficient area as defined by an adequate population, an acceptable level of competition and sufficient means of transport? Is the facility fully accredited and compliant with the Department of Health? What is the model of staffing, and what is the level of reliance, if any, on visiting consultants versus employed and more permanent medical staff? What is the funding structure for the planned expansions, and how long will the current financial resources last?

Most Common Questions

Is the Philippine healthcare system an investment opportunity? Yes, but the healthcare system is in a relatively underserved, high demand condition, especially in locations outside the major population centers. Though, the potential for revenue growth is highly dependent on the specific investment opportunity and the competencies of the operator, especially related to the challenges of regulation and staffing.

What are the more attractive subsectors of healthcare? Diagnostics, outpatient specialty care, and digital health rank the highest with respect to potential scalability and a quicker path to profitability versus full scale hospital development; which is the current industry standard.

What is the size of the healthcare industry? Per capita healthcare expenditure is expected to climb to USD 456 PPP by 2026. Currently pharmaceuticals and medical devices represent multi-billion and multi-hundred-million-dollar segments, respectively.

What difficulties do you anticipate in securing a return on investment? Consistently, high capital outlay, regulation and lack of skilled human resources are persistent and the most important issues new entrants face in this sector. They also matter more in the other Philippine industries.